Synthesis and characterization of
Anserine
Carnosine
Histidine dipeptides
Isotope dilution mass spectrometry
Quantitative analysis
Synthesis
Journal
Talanta
ISSN: 1873-3573
Titre abrégé: Talanta
Pays: Netherlands
ID NLM: 2984816R
Informations de publication
Date de publication:
01 Dec 2021
01 Dec 2021
Historique:
received:
30
04
2021
revised:
23
07
2021
accepted:
24
07
2021
entrez:
14
9
2021
pubmed:
15
9
2021
medline:
16
9
2021
Statut:
ppublish
Résumé
Due to the physiological properties of l-carnosine (l-1), supplementation of this dipeptide has both a nutritional ergogenic application and a therapeutic potential for the treatment of numerous diseases in which ischemic or oxidative stress are involved. Quantitation of carnosine and its analogs in biological matrices results to be crucial for these applications and HPLC-MS procedures with isotope-labeled internal standards are the state-of-the-art approach for this analytical need. The use of these standards allows to account for variations during the sample preparation process, between-sample matrix effects, and variations in instrument performance over analysis time. Although literature reports a number of studies involving carnosine, isotope-labeled derivatives of the dipeptide are not commercially available. In this work we present a fast, flexible, and convenient strategy for the synthesis of the
Identifiants
pubmed: 34517610
pii: S0039-9140(21)00663-9
doi: 10.1016/j.talanta.2021.122742
pii:
doi:
Substances chimiques
Dipeptides
0
Carnosine
8HO6PVN24W
Anserine
HDQ4N37UGV
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
122742Informations de copyright
Copyright © 2021 Elsevier B.V. All rights reserved.